Article info
Clinical science
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
- Correspondence to Dr Adnan Tufail, Department of Medical Retina Moorfields Eye Hospital NHS Trust, 162 City Road, London EC1V 2PD, UK; Adnan.Tufail{at}moorfields.nhs.uk
Citation
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Publication history
- Received October 5, 2014
- Revised December 11, 2014
- Accepted January 12, 2015
- First published February 13, 2015.
Online issue publication
July 21, 2015
Article Versions
- Previous version (13 February 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions